Cited by 929Eosinophilic Disorders and SyndromesImmunodeficiency and Autoimmune DisordersAsthma and respiratory diseases

The idiopathic hypereosinophilic syndrome

Open access
Weller, PF, Bubley, GJ·1994·Blood

Abstract

Values are percentages.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.v83.10.2759.2759

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Approximately 20% to 50% of patients with hypereosinophilic syndrome exhibit inflammation or fibrosis in the heart.

    “Approximately 20% to 50% of patients with hypereosinophilic syndrome exhibit inflammation or fibrosis in the heart”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [199]

    The Clinical Manifestations section describes cardiac disease as frequent in HES and says heart damage can progress from necrosis to fibrosis. The retrieved passages do not establish that inflammation or fibrosis occurs in approximately 20% to 50% of patients; the numerical range is unsupported by the available text. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Eosinophil-related autoimmune disorders are strongly linked to cardiovascular manifestations including myocarditis.

    “eosinophil-related autoimmune disorders are strongly linked to cardiovascular manifestations including myocarditis.”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [199]

    The Clinical Manifestations section says cardiac disease is frequent in hypereosinophilic syndrome and describes acute eosinophilic myocarditis. It does not establish that eosinophil-related autoimmune disorders, specifically, are strongly linked to these manifestations; it discusses hypereosinophilic syndrome and several other causes of eosinophilia. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Over 40% of patients with eosinophilic granulomatosis with polyangiitis experience cardiovascular complications.

    “over 40% of patients with eosinophilic granulomatosis with polyangiitis, also known as ChurgStrauss, experience cardiovascular complications.”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [199]

    The Clinical Manifestations section describes cardiac disease in idiopathic hypereosinophilic syndrome, while the Differential Diagnosis of HES section discusses Churg–Strauss syndrome without giving a rate of cardiovascular complications. Searches for Churg–Strauss cardiac involvement and 40% found no passage supporting the claimed proportion. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Spry CJF: Eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature. Oxford, UK, Oxford Medical Publications, 1988
  2. Chusid MJ, Dale DC, West BC, Wolff SM: The hypereo- sinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54: 1, 1975
  3. Spry CJ, Take M, Tai PC: Eosinophilic disorders affecting the myocardium and endocardium: A review. Heart Vessels Suppl 1:240, 1985
  4. Longworth DL, Weller PF: Hyperinfection syndrome with strongyloidiasis, in Remington JS, Swartz MN (eds): Current Clini- cal Topics in Infectious Diseases. New York, NY, McGraw-Hill, 1986, p l 293.
  5. Benvenisti DS, Ultmann JE: Eosinophilic leukemia. Report of five cases and review of literature. Ann Intern Med 71:731, 1969 300.

Cited by

Sorted by citations

Authors
Weller, P., & Bubley, G.
Venue
Blood
Published
1994-05-15
Volume
83
Issue
10
Pages
2759-2779
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W110944710
Cited by
929
References
1
Citations by year
2026: 8 · 2025: 21 · 2024: 24 · 2023: 13 · 2022: 29 · 2021: 22 · 2020: 20 · 2019: 19 · 2018: 19 · 2017: 24 · 2016: 27 · 2015: 29 · 2014: 38 · 2013: 35 · 2012: 42
FWCI
18.34
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute for Health and Care Research
  • National Institutes of Health (1p50hl046563-01, AI20241)
  • National Heart, Lung, and Blood Institute (HL-46563)
  • National Institute of Allergy and Infectious Diseases (AI22571, AI 20241, R01AI022571)
Topics
  • Health Sciences › Medicine › Rheumatology › Eosinophilic Disorders and Syndromes
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
Keywords
idiopathic hypereosinophilic syndrome, eosinophilia, hypereosinophilic syndrome
MeSH terms
Diagnosis, Differential, Humans, Hypereosinophilic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review